22 Nw, LP Anebulo Pharmaceuticals, Inc. Transaction History
22 Nw, LP
- $119 Million
- Q2 2025
A detailed history of 22 Nw, LP transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, 22 Nw, LP holds 15,467,300 shares of ANEB stock, worth $36.8 Million. This represents 18.72% of its overall portfolio holdings.
Number of Shares
15,467,300
Previous 15,467,300
-0.0%
Holding current value
$36.8 Million
Previous $20.1 Million
10.77%
% of portfolio
18.72%
Previous 18.74%
Shares
5 transactions
Others Institutions Holding ANEB
# of Institutions
20Shares Held
22.6MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$7.23 Million0.19% of portfolio
-
Mangrove Partners New York, NY2.53MShares$6.01 Million0.53% of portfolio
-
Morgan Stanley New York, NY399KShares$950,1410.0% of portfolio
-
Lvw Advisors, LLC350KShares$832,0880.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA216KShares$513,9630.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $61M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...